Root, Inc. enters this week's session in a curious spot. Short sellers have been reducing exposure steadily even as the stock has rallied 27% over the past month to $54.90. Yet the analyst community spent much of April and early May slashing price targets, placing the stock in a tug-of-war between technical momentum and fundamental scepticism.
The short-covering story is the most visible thread. SI as a percentage of free float has fallen from around 19% in early April to 14.9% now — a roughly 19% drop in total shares short over the past month. The pace of that retreat accelerated in two clear steps. The first came around April 9-10, when short interest fell sharply from roughly 2.51 million shares to around 2.19 million. The second step arrived between April 22-23, when a further 150,000 shares were covered, bringing the total to approximately 2.04 million. Days to cover, per FINRA data, stands at 6.3 — elevated for a stock seeing active covering. That suggests the remaining short base is meaningful and not purely passive.
Borrow conditions support the picture of an easing squeeze. Cost to borrow has dropped around 14% over the past week to 0.45%, well below the 0.94% spike seen on April 14. Availability, at roughly 21% of the lending pool currently occupied, is comfortably in normal territory and well below the 52-week high utilization of 40% recorded earlier in the year. There is no sign of a squeeze forcing shorts out; the covering looks more like deliberate position reduction than a panic unwind. The ORTEX short score of 63.3 places ROOT in the elevated range but has been drifting lower from a recent peak of 64.1 on April 22. Options positioning corroborates the lack of urgency — the put/call ratio of 0.35 is fractionally above its 20-day average, with a z-score under 0.6, telling a calm and broadly bullish story.
The analyst picture is harder to square with the price action. Target cuts have been the dominant theme across multiple firms over the past several months. Wells Fargo lowered its target to $52 on April 9, from $70 just weeks earlier; that's a below-market target on a stock now trading at $54.90. Keefe, Bruyette & Woods is more optimistic — the firm holds an Outperform and cut to $95 on April 7, implying meaningful upside. UBS, at Neutral with a $52 target set in early March, sits on the sceptical end. The mean price target of $68.50 implies roughly 25% upside from current levels, a reading flagged in the factor scores as a 51-percentile analyst recommendation differential — neutral territory, neither a strong buy nor a sell conviction. EV/EBITDA has expanded to 4.1x over the past month as the price rallied, but the multiple remains modest relative to insurance-tech peers. The P/E of 23.2x has risen 5.6 points over 30 days, tracking the stock's gains and absorbing them into a higher valuation.
The insider picture deserves a look, though the context tempers the signal. On April 1, a cluster of executives — including Founder and CEO Alex Timm, President Matt Bonakdarpour, and Chief Accounting Officer Megan Binkley — all sold shares. Timm sold around 32,000 shares, netting approximately $1.39 million. The same day, Timm also received an award of 62,969 shares, so the net position change is more modest than the gross sales suggest. The 90-day net across all insiders is actually positive at roughly 161,000 shares, skewed by those awards. Still, the sustained pace of executive selling through April is worth noting as the stock approaches and briefly exceeds some of the now-lowered analyst targets. Institutional flows show modest accumulation from BlackRock (+124k shares reported through April 30) and T. Rowe Price (+119k shares), providing a cushion of institutional demand underneath the stock.
Root reports Q1 2026 results on June 3. The prior earnings release, in February, triggered a 15% single-day drop and a 21% five-day loss — the most significant reaction in the visible history. Bears point to declining operating cash flow and shrinking unencumbered capital; bulls counter with 12% year-over-year growth in gross written premiums and a growing policy-in-force count now approaching 455,000. Close peer LMND was down 13% on the week while ROOT barely moved, a divergence that could reflect ROOT's relative momentum — or simply a lag. With targets being cut and the stock rallying through some of those cuts, the June print becomes the next major test of whether the fundamental thesis has kept pace with the price.
See the live data behind this article on ORTEX.
Open ROOT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
